| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.99.24.3188 |
| P698 | PubMed publication ID | 10377084 |
| P2093 | author name string | Peters K | |
| Isner JM | |||
| Magner M | |||
| Silver M | |||
| Kearney M | |||
| Couffinhal T | |||
| Sullivan A | |||
| Annex B | |||
| Witzenbichler B | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3188-3198 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice | |
| P478 | volume | 99 |
| Q42175358 | A novel targeted angiogenesis technique using VEGF conjugated magnetic nanoparticles and in-vitro endothelial barrier crossing |
| Q53291505 | A systematic approach to assess locoregional differences in angiogenesis. |
| Q31144747 | Adrenomedullin augments collateral development in response to acute ischemia |
| Q33606829 | Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization |
| Q34327373 | Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions |
| Q37645436 | Angiogenesis in the atherosclerotic plaque. |
| Q28611365 | Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis |
| Q90746458 | CD8+ T-cell plasticity regulates vascular regeneration in type-2 diabetes |
| Q35762857 | Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury |
| Q90461642 | Chronic Hindlimb Ischemia Assessment; Quantitative Evaluation Using Laser Doppler in a Rodent Model of Surgically Induced Peripheral Arterial Occlusion |
| Q36053227 | Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions |
| Q37534988 | Coronary vessel development and insight towards neovascular therapy. |
| Q33998452 | Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery |
| Q89900560 | Development of a two-stage limb ischemia model to better simulate human peripheral artery disease |
| Q37018405 | Divergent systemic and local inflammatory response to hind limb demand ischemia in wild-type and ApoE-/- mice |
| Q36935652 | Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. |
| Q33241243 | Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene |
| Q33620964 | Effects of VEGF temporal and spatial presentation on angiogenesis. |
| Q33779325 | Endothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia |
| Q37325660 | Endothelial progenitor cells: implications for cardiovascular disease |
| Q38966065 | Endothelial-targeted Gene Transfer of Hypoxia-inducible Factor-1α Augments Ischemic Neovascularization Following Systemic Administration |
| Q39737596 | Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q73606587 | Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy |
| Q36973708 | Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism |
| Q33734496 | Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors |
| Q42742048 | G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism |
| Q36477718 | Gene therapy of the ischemic lower limb--Therapeutic angiogenesis. |
| Q79085598 | Genetic background influences therapeutic effectiveness of VEGF |
| Q36279045 | Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers |
| Q35828530 | Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis |
| Q44920270 | Hypercholesterolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: possible role of VEGF downregulation in brain |
| Q33500964 | IRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia |
| Q36403317 | Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2. |
| Q38952702 | Limb ischemia and vessel regeneration: Is there a role for VEGF? |
| Q90167859 | Lowering circulating apolipoprotein E levels improves aged bone fracture healing |
| Q40428568 | Lysine acetyltransferase PCAF is a key regulator of arteriogenesis. |
| Q38260351 | Manipulating the intersection of angiogenesis and inflammation |
| Q37071924 | Massive T-lymphocyte infiltration into the host stroma is essential for fibroblast growth factor-2-promoted growth and metastasis of mammary tumors via neovascular stability. |
| Q37141583 | Methods for Acute and Subacute Murine Hindlimb Ischemia |
| Q34033191 | Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles |
| Q36607821 | Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems |
| Q74176519 | Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice |
| Q92677852 | Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling |
| Q35949615 | Nitric oxide signaling during myocardial angiogenesis |
| Q33195322 | Peripheral nerve ischemia: apolipoprotein E deficiency results in impaired functional recovery and reduction of associated intraneural angiogenic response. |
| Q33287995 | Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution |
| Q44001353 | Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats. |
| Q33681553 | Redox regulation of ischemic limb neovascularization - What we have learned from animal studies |
| Q98298303 | Regulatory T cells in ischemic cardiovascular injury and repair |
| Q34959073 | Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. |
| Q24304277 | Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 |
| Q30419462 | Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice |
| Q30430026 | Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications |
| Q41652067 | Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density |
| Q33517020 | Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis |
| Q34776009 | Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. |
| Q45067961 | Temporal remodeling of pial collaterals and functional deficits in a murine model of ischemic stroke |
| Q38103601 | The future of collateral artery research |
| Q35949638 | Therapeutic myocardial angiogenesis with vascular endothelial growth factors |
| Q49991844 | Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization. |
| Q34023655 | Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle |
| Q35111623 | Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization |
| Q37253996 | Transplanted Endothelial Progenitor Cells Improve Ischemia Muscle Regeneration in Mice by Diffusion Tensor MR Imaging |
| Q92488357 | Treating ischemia via recruitment of antigen-specific T cells |
| Q44608956 | Up-Regulation of Matrix Metalloproteinase-9 in T Lymphocytes of Mammary Tumor Bearers: Role of Vascular Endothelial Growth Factor |
| Q73033342 | VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease |
| Q40631726 | Vascular endothelial growth factor modulates skeletal myoblast function |
| Q77565513 | [The mechanisms of angiogenesis. Medical and therapeutic applications] |
Search more.